Edition:
United States

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

5.15USD
3:59pm EST
Change (% chg)

$0.12 (+2.39%)
Prev Close
$5.03
Open
$5.00
Day's High
$5.18
Day's Low
$5.00
Volume
28,494
Avg. Vol
59,145
52-wk High
$6.96
52-wk Low
$2.42

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.32 December 16 Nov 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 2 2 2
(2) OUTPERFORM 5 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 6 5.27 5.92 4.90 9.12
Quarter Ending Mar-19 5 5.61 7.00 4.00 --
Year Ending Dec-18 6 18.22 18.85 17.90 34.87
Year Ending Dec-19 6 33.41 53.15 26.80 59.75
Earnings (per share)
Quarter Ending Dec-18 6 -0.32 -0.27 -0.39 -0.14
Quarter Ending Mar-19 4 -0.21 -0.11 -0.28 --
Year Ending Dec-18 6 -1.43 -1.34 -1.60 -0.93
Year Ending Dec-19 6 -0.69 -0.10 -1.00 -0.21

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-18 4.69 4.23 0.46 9.77
Quarter Ending Jun-18 5.50 4.66 0.84 15.26
Quarter Ending Mar-18 6.19 4.04 2.15 34.70
Quarter Ending Dec-17 6.69 12.00 5.31 79.47
Quarter Ending Sep-17 6.46 4.73 1.74 26.84
Earnings (per share)
Quarter Ending Sep-18 -0.31 -0.33 0.02 -6.45
Quarter Ending Jun-18 -0.31 -0.34 0.03 -8.52
Quarter Ending Mar-18 -0.31 -0.39 0.08 -26.83
Quarter Ending Dec-17 -0.31 -0.29 0.02 -7.20
Quarter Ending Sep-17 -0.42 -0.58 0.16 -37.02

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 5.27 5.50 5.89 7.69 9.12
Quarter Ending Mar-19 5.61 5.29 4.72 6.49 --
Year Ending Dec-18 18.22 18.87 19.37 22.15 34.87
Year Ending Dec-19 33.41 33.90 35.54 50.41 59.75
Earnings (per share)
Quarter Ending Dec-18 -0.32 -0.31 -0.31 -0.24 -0.14
Quarter Ending Mar-19 -0.21 -0.21 -0.24 -0.22 --
Year Ending Dec-18 -1.43 -1.36 -1.37 -1.24 -0.93
Year Ending Dec-19 -0.69 -0.67 -0.75 -0.49 -0.21

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 3 0 2
Quarter Ending Mar-19 0 0 0 0
Year Ending Dec-18 1 4 1 3
Year Ending Dec-19 0 3 0 3
Earnings
Quarter Ending Dec-18 1 3 1 2
Quarter Ending Mar-19 1 0 1 0
Year Ending Dec-18 2 4 2 3
Year Ending Dec-19 2 3 2 3